MOSCOW (Sputnik) – The clinical trials for the vaccine are in their final stages:
"We expect that those who are heading… to potential hotbeds [of the disease], we shall vaccinate them as a test group straight away," the official added.
The most recent Ebola outbreak began in December 2013, spreading from Guinea to Liberia and Sierra Leone and killing over 11,000 people in these three countries. Liberia officially declared an end to the epidemic on its soil in October.
Russia has pledged to spend $11.7 million over three years on joint research with Guinea to combat infectious diseases and to train medical personnel.
In October, the Russian Health Ministry said the vaccine had been tested on around 200 volunteers and was "very well tolerated," with a low percentage of minor side effects.